A private company striving to map the human genetic code reported today that it has completed a major step in the project - sequencing the genome.
Published:
7 April 2000 y., Friday
Celera Genomics of suburban Rockville, Md., said it has finished the sequencing phase of one person_s genetic code and will now begin to assemble the genetic fragments into their proper order.
The human genome is a biological map laying out the exact sequence of the estimated 3.5
billion pairs of chemicals that make up the DNA in each human cell. Those chemicals are
arranged in specific ways to create the estimated 80,000 to 100,000 human genes, which in
turn carry the instructions for all the body_s processes.
Understanding the massive series of genes that provide the code for life has been a major
project for both private and public organizations for several years, because it could serve as
the foundation for developing new medical cures and preventions.
Celera is a private company that is competing with government researchers to decode the
human genome. But to do so, it uses portions of the genome already sequenced by the nonprofit Human Genome Project, which posts on the Internet each bit of DNA it
completes decoding. The Human Genome Project has posted 2.3 billion subunits of DNA that it has decoded on the Internet for use by any scientist.
In contrast to how Celera sequences DNA, the Human Genome Project fits the genetic
puzzle pieces together as they are discovered, accumulating larger - and what it calls more
accurate - pieces. The Human Genome Project also expects to complete a ``working draft'' of the genome
later this year, and to publish a full genetic map on the Internet by 2003.
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.
The most popular articles
The only physician in her village of Tsoniarisi, Mzevinar Bolkvadze sees patients all day in a newly built and equipped ambulatory.
more »
As of 7 September 2009, 48 of the 53 Member States in the WHO European Region had reported over 49 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
China's food and drug administration say clinical trials of a vaccine against the H1N1 flu strain have been successful.
more »
As of 31 August 2009, 48 of the 53 Member States in the WHO European Region had reported laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
The European Union Health Security Committee and the Early Warning and Response authorities adopted a policy statement proposed by the European Commission which outlines a shared European approach towards identifying target and priority groups for A H1N1 vaccination.
more »
As of 20 August 2009, 47 of the 53 Member States in the WHO European Region had reported over 42 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
About 1000 participants, mostly from North America, debated solutions to the obesity epidemic in the United States (US) at the Weight of the Nation conference, organized in Washington, USA, by the US Centers for Disease Control.
more »
The European Union Health Security Committee and the Early Warning and Response authorities (HSC/EWRS) unanimously adopted for the first time two policy statements proposed by the European Commission on public health measures for pandemic influenza A (H1N1) 2009.
more »
As of 10 August 2009, 46 of the 53 countries in the WHO European Region had reported over 33 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection, including 55 fatalities in 7 countries.
more »
The U.S. company Moog Medical Devices which acquired the company the Lithuanian Viltechmeda at the beginning of the year 2009, intends to invest EUR 2M in Lithuania in the nearest future, to establish a modern services centre.
more »